capitolbuilding
Issue Background

Federal Legislation

Infection Prevention Funding in FY 2019

Below is a chart outlining how infection prevention programs fared this year when compared to the previous year. 

Federal Government Program

FY 2018

FY 2019

Emerging and Zoonotic Infectious Diseases Programs

   

Antibiotic Resistance Initiative

$168,000,000

$168,000,000

National Healthcare Safety Network

$21,000,000

$21,000,000

Advanced Molecular Detection

$30,000,000

$30,000,000

Prevention and Public Health Fund (PPHF)

   

Immunizations

$324,350,000

$320,500,000

Epidemiology and Lab Capacity program

$40,000,000

$40,000,000

Healthcare-Associated Infections

$12,000,000

$12,000,000

Agency for Healthcare Research and Quality (AHRQ)

   

AHRQ baseline funding

$334,000,000

$338,000,000

Healthcare-Associated Infections Prevention

$36,000,000

$36,000,000

National Institutes of Health (NIH)

   

National Institute of Allergy and Infectious Diseases

$5,260,210,000

$5,523,000,000



 

2018 Testimony and Fact Sheets

  • On September 7, the Friends of AHRQ coalition sent a letter requesting the House and Senate Appropriations Committees continue to fund AHRQ at a minimum of $334 million. 
  • On July 12, the Stakeholder Forum on Antimicrobial Resistance (S-FAR) sent a letter expressing support for the REVAMP Act: Re-Valuing Antimicrobial Products of 2018 (H.R.6294) which encourages companies to invest in new antimicrobials by allowing anyone creating a new antibiotic an additional year of exclusivity for another drug. 
  • On June 13, the CDC Coalition sent a letter expressed opposition to using the Prevention and Public Health Fund to offset projected spending in the Puerto Rice Economic Empowerment Act. 
  • On June 8, the Stakeholder Forum on Antimicrobial Resistance (S-FAR) sent a letter to members of the Appropriations Committee requesting funding for key infection prevention and control programs. 
  • On April 26, APIC and SHEA submitted joint testimony to the House Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies asking the subcommittee to support key infection prevention programs.  
  • On April 9, the CDC Coalition submitted a letter to the House and Senate Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies requesting them to fund the CDC at $8.445 billion. 
  • On March 19, APIC joined a coalition letter being led by the American Thoracic Society requesting members of Congress increase funding for domestic and international tuberculosis programs. 
  • On March 12, APIC joined a coalition letter urging the Assistant Secretary for Preparedness and Response (R&D) support new antimicrobial research and development (R&D) incentives in the reauthorization of the Pandemic and All Hazards Preparedness Act (PAHPA).
  • On February 26, APIC joined a S-FAR coalition letter in supporting the Strategies to Address Antimicrobial Resistance (STAAR) Act which was introduced by Senator Sherrod Brown. 
  • On February 6, a coalition of more than 50 organizations signed a letter encouraging Members of Congress to include an amendment to the Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization legislation. The letter encourages legislators to incentivize companies to develop new antimicrobials.
  • APIC signed another coalition letter asking Members of Congress not to cut any more funding from the Prevention and Public Health Fund. 
  • On January 8, APIC joined the Friends of AHRQ on a coalition letter asking Members of Congress to support equal or higher funding for the Agency for Healthcare Research and Quality (AHRQ). 


2017 Testimony and Fact Sheets

Coalition Efforts

  • APIC signed onto a coalition letter urging the National Institute of Food and Agriculture to protect antibiotic research funding in FY 2018. 
  • The CDC Coalition signed a letter asking Congressional appropriators to provide the CDC with $7.8 billion in FY 2018. 
  • On October 23, APIC joined a coalition letter signed by 68 other organizations urging Congress to provide emergency supplemental funding to states impacted by hurricanes.  
  • The Friends of the National Quality Forum (NQF) wrote a letter to Chairman Kevin Brady urging him to continue the currently authorized $30 million in annual Medicare funding for the National Quality Forum. 
  • The U.S. Stakeholder Forum on Antimicrobial Resistance (S-FAR) sponsored a letter requesting Congress reject the President's FY 2018 budget and to create a bipartisan plan that provides the funding needed to address public health threats.  
  • More than 800 organizations, signed a letter asking the House and Senate Appropriations Committees to increase the FY 2018 302 (b) allocation for the Labor, HHS and Education subcommittees. 
  • The CDC Coalition signed a letter asking Congressional appropriators to provide the CDC with $7.8 billion in FY 2018. 
  • Coalition letter to the Acting Commissioner of the FDA asking the them to strenghten rules regarding labels on antibiotics for food animals. 
  • A coalition of over 2,000 organizations signed a letter requesting Members of Congress help protect non-defense discretionary spending in FY 2018. 
  • A wide-ranging coalition of health professionals, patient advocacy groups and veterinarians signed a letter urging President Trump not to include federal public health employees in his potential long-term hiring freeze Executive Order. 
  • The March of Dimes led a coalition effort requesting Senate Appropriators support funding levels necessary to properly combat Zika in FY2018. 
  • coalition letter sent to President Trump emphasized the importance and safety of vaccinations. 
  • APIC signed a coalition letter urging the Senate HELP and Finance Committees to use Representative Tom Price's confirmation hearings to ensure his support for immunization policy and infrastructure. 

Congressional Hearings related to infection prevention